Article
Molecular tests for colorectal cancer screening.
Clinical colorectal cancer - 1 Mar 2011
Bosch Linda J W, Carvalho Beatriz, Fijneman Remond J A, Jimenez Connie R, Pinedo Herbert M, van Engeland Manon, Meijer Gerrit A
Abstract excerpt
Detecting and removing high-risk adenomas and early colorectal cancer (CRC) can reduce mortality of this disease. The noninvasive fecal occult blood test (FOBT; guaiac-based or immunochemical) is widely used in screening programs and although effective, it leaves room for improvement in terms of test accuracy. Molecular tests are expected to be more sensitive, specific and informative than current detection...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.